ROBINS HARLAN S plan to sell securities of Adaptive Biotechnologies Corp under Form 144

ROBINS HARLAN S filed Form 144 to notify SEC of plan to sell 470266 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $6,828,262.32. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.31% of total outstanding units; Recent transactions in past 3 months include: On 03/03/2026, sold 14233 units for $235129.16; On 03/02/2026, sold 10000 units for $157239.00; On 02/03/2026, sold 515 units for $9960.00; On 02/03/2026, sold 7605 units for $144288.14; On 02/02/2026, sold 2395 units for $44130.99; On 02/02/2026, sold 32273 units for $600732.85; On 01/06/2026, sold 10000 units for $164412.00;